134 related articles for article (PubMed ID: 3072534)
1. Mechanism of actions of cholecystokinin octapeptide on food intake and insulin and pancreatic polypeptide release in the dog.
Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Ogawa T; Mizuno N; Baba S
Peptides; 1988; 9(5):1093-100. PubMed ID: 3072534
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular administration of cholecystokinin-8 elevates plasma pancreatic polypeptide levels in awake dogs.
Lu QH; Greeley GH; Zhu XG; Thompson JC
Endocrinology; 1984 Jun; 114(6):2415-7. PubMed ID: 6327247
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of insulin secretion by intracerebroventricular infusion of pancreatic polypeptide in conscious dogs].
Inui A
Nihon Naibunpi Gakkai Zasshi; 1985 Aug; 61(8):835-46. PubMed ID: 3908154
[TBL] [Abstract][Full Text] [Related]
4. Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
Kuvshinoff BW; Brodish RJ; Fink AS; McFadden DW
J Surg Res; 1994 May; 56(5):397-401. PubMed ID: 8170138
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
Schick RR; Yaksh TL; Go VL
Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
[TBL] [Abstract][Full Text] [Related]
6. The role of cholecystokinin octapeptide in the central control of food intake in the dog.
Sakatani N; Inui A; Inoue T; Oya M; Morioka H; Baba S
Peptides; 1987; 8(4):651-6. PubMed ID: 3306623
[TBL] [Abstract][Full Text] [Related]
7. Central cholinergic regulation of pancreatic polypeptide secretion in conscious dogs.
Okita M; Inui A; Baba S; Kasuga M
J Endocrinol; 1997 Aug; 154(2):311-7. PubMed ID: 9291842
[TBL] [Abstract][Full Text] [Related]
8. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
[TBL] [Abstract][Full Text] [Related]
10. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
Sakatani N; Inui A; Baba S
Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
[TBL] [Abstract][Full Text] [Related]
11. Differential antagonism by proglumide of various CCK-mediated effects in mice.
Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular CCK inhibits food intake and gastric emptying in baboons.
Figlewicz DP; Sipols AJ; Porte D; Woods SC; Liddle RA
Am J Physiol; 1989 Jun; 256(6 Pt 2):R1313-7. PubMed ID: 2735457
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin stimulates neuronal receptors to produce contraction of the canine colon.
Barone FC; Bondinell WE; Labosh TJ; White RF; Ormsbee HS
Life Sci; 1989; 44(8):533-42. PubMed ID: 2927258
[TBL] [Abstract][Full Text] [Related]
14. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
[TBL] [Abstract][Full Text] [Related]
15. Physiologic role of cholecystokinin in the intestinal phase of pancreatic polypeptide release.
Fried GM; Ogden WD; Greeley GH; Thompson JC
Ann Surg; 1984 Nov; 200(5):600-4. PubMed ID: 6486910
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog.
Niebel W; Eysselein VE; Singer MV
Dig Dis Sci; 1987 Sep; 32(9):1004-9. PubMed ID: 3622184
[TBL] [Abstract][Full Text] [Related]
17. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
[TBL] [Abstract][Full Text] [Related]
19. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of proglumide and CR 1409, a new glutaramic acid derivative, on CCK-8-induced pancreatic polypeptide and insulin secretion in the dog.
Inui A; Oya M; Inoue T; Sakatani N; Morioka H; Baba S
Horm Metab Res; 1988 Jan; 20(1):61-2. PubMed ID: 3286447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
